Fresh Equities
Raises
Markets
About
Looking for more information?

Contact our responsive and friendly client services team any time.

(03) 9028 2888

clients@freshequities.com

ASX:DXB logo

ASX:DXB

Dimerix Limited

Health Care / Biotechnology

Current price

$0.26

0.005 (1.96%)

Last trade: Invalid date GMT

Market cap

$51.48m

Market closed

Investor Presentations

Principal Activity

Dimerix is a clinical stage drug development company. The Company’s lead drug candidate DMX-200 is a chemokine receptor blocker. The Company’s clinical plan involves combining DMX-200 with Irbesartan, a angiotensin receptor blocker indicated for the treatment of hypertension and nephropathy in patients with kidney disease. DMX-200 is currently being tested in two Phase II clinical trials. Both trials are fully recruited and are due to report results in Q2 2020. The first study is targetting the rare chronic kidney disease FSGS and the second is targetting diabetic kidney disease. DMX-200 was discovered using the Company’s proprietary Receptor-HIT assay. Recently the Company announced that it had discovered its next pipeline candidate using the assay, DMX-700. DMX-700 will be investigated for the use in treating Chronic Obstructive Pulmonary Disease.


Address

5/95 Hay St, Subiaco WA 6008, Australia

News

Announcements

Filter

All categories
Investor Presentations
Trading Halt
Qtly Cashflow
Issued Capital
Periodic Reports
AnnouncementT+2 MovementDate

Rows per page:

5

6-10 of 10

Market Data

Day

3m

1yr

5yr

Current price

-

Open price

-

Day low-high

-

Price change

-

Percent change

-

Previous close

-

Volume

-

Turnover

-

Bid price

-

Ask price

-

Market cap

-

Shares outstanding

-

Year high

-

Year low

-

Year low-high

-

Earnings per share

-

Price/earnings ratio

-

Dividend yield

-

Dividend per share

-

Franking

-

Investor Presentations

News

Sector Peers

CompanyMarket Cap
Fresh Equities
App Store
Play Store

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 19, 15 William St
Melbourne VIC 3000
Australia

App Store
Play Store

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.